ArticleEuropean journal of clinical pharmacology2024
Socioeconomic factors associated with poor medication adherence in patients with type 2 diabetes.
Article in European journal of clinical pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 20 citations in OpenAlex.
- The role of health literacy in medication adherence among people living with multiple sclerosis: a cross-sectional study in Isfahan, Iran.BMC neurology · 2026Article
- Article
- The Impact of the Multidisciplinary Team on Medication Adherence in Type 2 Diabetes: A Narrative Review.Journal of multidisciplinary healthcare · 2026Review
- Factors associated with treatment compliance among middle-aged patients with type 2 diabetes mellitus in King Abdulaziz University Hospital, Jeddah, Saudi Arabia.Frontiers in clinical diabetes and healthcare · 2026Article
- Impact of complex medication regimens on adherence in multimorbidity senior citizen - Study from Nepal.PloS one · 2026Article
- Adapting a medication adherence app for adolescents and young adults in Makurdi, Benue State: The Lu Dedoo Project.PloS one · 2026Article
- The impact of socio-economic deprivation on the long-term survival of people with diabetes and acute myocardial infarction: A nationwide cohort study.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
- Improved medication adherence and health literacy in parents of children with ADHD: Effects of a targeted educational program.Exploratory research in clinical and social pharmacy · 2025Article
- Differential use of antidiabetic medication related to income, cohabitation and area of residence: a Swedish nationwide cohort study.Journal of epidemiology and community health · 2025Article
- Article
- Exploring the impact of the Index of Multiple Deprivation on percutaneous coronary intervention outcomes: Insights from the British Cardiovascular Intervention Society database.Global cardiology science & practice · 2025Article
- Review
- Relationship Between Depression and Decreased Activity Level and Cognitive Impairment in Patients with Diabetes Mellitus Type 2 and/or Atrial Fibrillation.Journal of clinical medicine · 2025Article
- Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.Patient preference and adherence · 2025Article
- Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services.Journal of the American College of Clinical Pharmacy : JACCP · 2025Article
- Preclinical pharmacological profiles of cofrogliptin, a novel and bi-weekly DPP-4 inhibitor.Frontiers in pharmacology · 2025Article
- Non-dispensed prescriptions - A nationwide descriptive study.Exploratory research in clinical and social pharmacy · 2024Article
- Minding the gap: Assessing patient expectations versus experiences in drug information services at community health centers (Narra J · 2024Article
- Asthma medication adherence, control, and psychological symptoms: a cross-sectional study.BMC pulmonary medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to determine initiation and persistence for patients with type 2 diabetes receiving their first prescription of an antidiabetic agent and the associations with socioeconomic factors.
methodsA cohort study including 8515 patients with type 2 diabetes who were prescribed their first antidiabetic medication between 2012 and 2019 in Uppsala, Sweden, was followed during 2 years. Medical records were linked to national registers on dispensed drugs and socioeconomic data. Adherence was assessed based on patients' medication claims within 30 days of prescription (initiation) and continued claims after 24 months (persistence). Multivariable logistic regression was used to determine the associations with the socioeconomic factors age, sex, living status, country of birth, education, occupation, and income.
resultsWithin 30 days, 92.4% of the patients claimed their first prescription, and 64.0% were still being dispensed the initially prescribed medication after 24 months. Unemployed patients had lower initiation rates, and women had lower persistence rates. Factors associated with both low initiation and persistence were low income, young or old age, birth outside Europe, and being prescribed other diabetes drugs than metformin monotherapy.
conclusionSocioeconomic factors have different impact on the initiation of a new medication and the persistence to treatment in type 2 diabetes. It is important to acknowledge these differences to develop appropriate interventions to improve medication nonadherence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.